➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ALLOPURINOL

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Allopurinol

Subscribe to access the full database, or Get Started for $10
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00004314	Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease	Completed	University of California, San Diego	Phase 2	1996-02-01	OBJECTIVES: I. Determine the effects of aminoimidazole carboxamide riboside (AICAR) on hematologic manifestations of Lesch-Nyhan disease. II. Assess the behavioral and neurological benefits of AICAR in patients with Lesch-Nyhan disease. III. Examine the effect of AICAR on purine production.
NCT00004314	Phase II Pilot Study of Aminoimidazole Carboxamide Riboside (AICAR), a Precursor of Purine Synthesis, for Lesch-Nyhan Disease	Completed	National Center for Research Resources (NCRR)	Phase 2	1996-02-01	OBJECTIVES: I. Determine the effects of aminoimidazole carboxamide riboside (AICAR) on hematologic manifestations of Lesch-Nyhan disease. II. Assess the behavioral and neurological benefits of AICAR in patients with Lesch-Nyhan disease. III. Examine the effect of AICAR on purine production.
NCT00004755	Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil	Completed	Harvard School of Public Health	Phase 2	1995-09-01	OBJECTIVE: Compare the efficacy and side effects of allopurinol versus glucantime versus allopurinol/glucantime in patients in Brazil with cutaneous leishmaniasis.
NCT00004755	Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	1995-09-01	OBJECTIVE: Compare the efficacy and side effects of allopurinol versus glucantime versus allopurinol/glucantime in patients in Brazil with cutaneous leishmaniasis.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Allopurinol

Condition Name

Chart
Table

Condition Name for Allopurinol
Intervention	Trials
Gout	37
Hyperuricemia	17
Leukemia	16
Chronic Lymphocytic Leukemia	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Allopurinol
Intervention	Trials
Leukemia	30
Gout	28
Leukemia, Lymphoid	27
Hyperuricemia	25
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Allopurinol

Trials by Country

Map
Table

Trials by Country for Allopurinol
Location	Trials
United States	637
Canada	47
Australia	23
Spain	17
Germany	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Allopurinol
Location	Trials
Texas	56
California	31
Florida	24
North Carolina	23
New York	21
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Allopurinol

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Allopurinol
Clinical Trial Phase	Trials
Phase 4	39
Phase 3	38
Phase 2/Phase 3	6
[disabled in preview]	60
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Allopurinol
Clinical Trial Phase	Trials
Completed	84
Recruiting	28
Not yet recruiting	27
[disabled in preview]	20
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Allopurinol

Sponsor Name

Chart
Table

Sponsor Name for Allopurinol
Sponsor	Trials
M.D. Anderson Cancer Center	22
Ardea Biosciences, Inc.	14
AstraZeneca	9
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Allopurinol
Sponsor	Trials
Other	223
Industry	84
NIH	23
[disabled in preview]	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

McKesson

Merck

Baxter

Mallinckrodt

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.